{"brief_title": "Safety and Efficacy Trial of the Use of Quetiapine Fumarate (SEROQUEL\u00ae) in the Treatment of Patients With Bipolar Depression", "brief_summary": "The purpose of this study is to evaluate the efficacy and safety of quetiapine in the treatment of a major depressive episode in patients with bipolar disorder.", "condition": ["Bipolar Disorder", "Depression, Bipolar"], "intervention_type": ["Drug"], "intervention_name": ["SEROQUEL (quetiapine fumarate) Tablets"], "criteria": "Inclusion Criteria: - Written Informed Consent; - Bipolar disorder with most recent episode depressed; - Outpatient status Exclusion Criteria: - Patients with a current Axis I disorder other than bipolar disorder within 6 months of screening; - Patients whose current episode of depression exceeds 12 months or is less than 4 weeks", "gender": "All", "minimum_age": "18 Years", "maximum_age": "65 Years", "healthy_volunteers": "No", "keyword": "Bipolar Depression", "mesh_term": ["Depression", "Depressive Disorder", "Bipolar Disorder", "Quetiapine Fumarate"], "id": "NCT00060489"}